CLINICAL_TRIALS
trial_result
· 2016-02-12
Clinical Trial Update: Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months
Summary
A completed clinical trial assessing the effects of Aubagio (teriflunomide) on brain pathology in people with multiple sclerosis over 12 months.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University at Buffalo | Conditions: Multiple Sclerosis | Status: COMPLETED